Revvity Inc. (RVTY) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Revvity Inc. stock (RVTY) is currently trading at $87.84. Revvity Inc. PE ratio is 42.46. Revvity Inc. PS ratio (Price-to-Sales) is 3.42. Analyst consensus price target for RVTY is $119.56. WallStSmart rates RVTY as Hold.
- RVTY PE ratio analysis and historical PE chart
- RVTY PS ratio (Price-to-Sales) history and trend
- RVTY intrinsic value — DCF, Graham Number, EPV models
- RVTY stock price prediction 2025 2026 2027 2028 2029 2030
- RVTY fair value vs current price
- RVTY insider transactions and insider buying
- Is RVTY undervalued or overvalued?
- Revvity Inc. financial analysis — revenue, earnings, cash flow
- RVTY Piotroski F-Score and Altman Z-Score
- RVTY analyst price target and Smart Rating
Revvity Inc.
📊 No data available
Try selecting a different time range
RVTY Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Revvity Inc. (RVTY)
RVTY trades 83% above its Graham fair value of $55.21, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Revvity Inc. (RVTY) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, operating margin, price/book. Concerns around return on equity. Fundamentals are solid but monitor weak areas for improvement.
Revvity Inc. (RVTY) Key Strengths (5)
Growing significantly faster than its price suggests
103.07% of shares held by major funds and institutions
Strong operational efficiency: $20 kept per $100 revenue
Trading at 1.32x book value, attractively priced
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Revvity Inc. (RVTY) Areas to Watch (5)
Very low returns on shareholder equity
Modest revenue growth at 5.90%
Thin profit margins with limited profitability
Revenue is fairly priced at 3.42x sales
Solid earnings growth at 12.50%
Supporting Valuation Data
Revvity Inc. (RVTY) Detailed Analysis Report
Overall Assessment
This company scores 63/100 in our Smart Analysis, earning a C+ grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.6/10) while 5 fall into concern territory (avg 4.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Institutional Own., Operating Margin. Valuation metrics including PEG Ratio (0.53), Price/Book (1.32) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 20.10%.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, Profit Margin. Some valuation metrics including Price/Sales (3.42) suggest expensive pricing. Growth concerns include Revenue Growth at 5.90%, EPS Growth at 12.50%, which may limit upside. Profitability pressure is visible in Return on Equity at 3.22%, Profit Margin at 8.45%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 3.22% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 5.90% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Institutional Own.) and negatives (Return on Equity, Revenue Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
RVTY Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
RVTY's Price-to-Sales ratio of 3.42x sits near its historical average of 3.57x (29th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 12% below its historical high of 3.9x set in Mar 2026, and 2% above its historical low of 3.36x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~3.9x as trailing revenue scaled faster than the stock price.
Compare RVTY with Competitors
Top DIAGNOSTICS & RESEARCH stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Revvity Inc. (RVTY) · HEALTHCARE › DIAGNOSTICS & RESEARCH
The Big Picture
Revvity Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 2.9B with 6% growth year-over-year. Profit margins are thin at 8.4%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 322.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 163M in free cash flow and 183M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can Revvity Inc. push profit margins above 15% as the business scales?
Sector dynamics: monitor DIAGNOSTICS & RESEARCH industry trends, competitive moves, and regulatory changes that could impact Revvity Inc..
Bottom Line
Revvity Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Revvity Inc.(RVTY)
NYSE
HEALTHCARE
DIAGNOSTICS & RESEARCH
USA
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.